Breaking News on Pharmaceutical Technology

Product news > Drug delivery systems

Latest news headlines

Products

Suppliers

Gelatine-based vectors offer smoother passage for gene therapy

19-Apr-2007 - Gelatine-based nanoparticles may offer a new delivery route for gene therapy that skirts the complications of viral-based vectors.

SCOLR pushes ahead with 12-hour ibuprofen

18-Apr-2007 - Drug delivery specialist SCOLR Pharma plans to file a US New Drug Application (NDA) in the latter half of 2008 for a 12-hour tablet formulation of the painkiller ibuprofen.

New technologies, needs will spur transdermal/transmucosal delivery

18-Apr-2007 - A combination of new drugs, new patient needs and new technologies is likely to fuel steady growth in the transdermal/transmucosal drug delivery market during the years to 2010.

Dose-by-dose does it for 3M

18-Apr-2007 - A new integrated dose counter is being launched this week by 3M's drug delivery systems business, providing a new solution to recent regulatory requirements for metered dose inhalers.

Skye formulation accepted for GSK drug

16-Apr-2007 - UK firm SkyePharma last week announced that the US Food and Drug Administration (FDA) has accepted a filing for the extended release formulation of partner GlaxoSmithKline's (GSK) drug Requip (ropinirole).

Polymeric pain relief product to hit the shelves

16-Apr-2007 - US firm Skinvisible last week announced that its polymer-based delivery system has been licensed to pain relief company DRJ for use in a new topical analgesic product.

Exubera has opened door for pulmonary delivery growth

16-Apr-2007 - While the market performance of Exubera may have fallen short of expectations, Pfizer's inhaled insulin has opened the door for a wider variety of macromolecules to take the pulmonary delivery route.

DHS clarifies rules on plant security

11-Apr-2007 - New federal security regulations for high-risk chemical facilities in the US will not automatically take precedence over tougher provisions on chemical security already introduced by some states.

DOR's oral leuprolide to start trials mid-year

11-Apr-2007 - US company DOR BioPharma plans to start clinical trials in the next few months with what could be the first oral formulation of the widely used prostate cancer treatment leuprolide.

Microneedle tech to boost intradermal drug delivery

05-Apr-2007 - Drug delivery technology firm Apogee has signed an exclusive licence to get its hands on a microneedle-based drug delivery technology that it hopes will significantly enhance the company's PyraDerm intradermal drug delivery system.

Becton Dickinson broaches US safety pen market

04-Apr-2007 - Becton Dickinson (BD) has extended its existing franchise in safety injection products and insulin delivery technologies into the safety pen needle market, with the US launch of the BD AutoShield Pen Needle.

Pfizer spies pSivida's injectable eye treatment

04-Apr-2007 - Pfizer has homed in pSivida's controlled release drug delivery technology, signing a research and licensing deal worth $165m (€123.5m) and focusing keenly on the company's Medidur technology for new ophthalmic applications.

Adams taps into MonoSol's fast-dissolve technology

03-Apr-2007 - A thin-film delivery system that looks like a postage stamp and dissolves rapidly on the tongue could give new momentum to Adams Respiratory Therapeutics' portfolio of prescription and over-the-counter medicines (OTC) for the treatment of respiratory disorders.

Sunny Skyes as injectables business falls to earth

29-Mar-2007 - UK firm SkyePharma has announced that it has finally completed the sale of its deadweight injectable business, freeing up the company to focus on the development of products that the company believes could rival those of the pharma big guns.

Turning over a new leaf with cellulose drug delivery

28-Mar-2007 - A new cellulose-based drug delivery system could be on the horizon, according to a research team presenting their work this week in the US.

Medical House autoinjector project into next phase

26-Mar-2007 - UK drug delivery and orthopaedic devices company The Medical House (TMH) is entering the second phase of a development project for a European defence agency involving its AutoSafety Injector (ASI) disposable autoinjector technology for the administration of pharmaceutical products in prefilled syringes.

Nanocrystals could be route to carrier-free drug delivery

21-Mar-2007 - A novel method of delivering a hydrophobic (water-insoluble) drug, in which the compound effectively acts as its own carrier, has shown comparable efficacy both in vitro and in vivo to the same drug formulated in a conventional delivery vehicle.

Micro-jets for painless needle-free injections

13-Mar-2007 - Novel needle-free injections that don't cause the pain and bruising common with existing needle-free devices have been developed by a team in California.

Oestrogen patch safer than pill

12-Mar-2007 - Amidst swirling concerns over the side-effects of oestrogen replacement therapy in postmenopausal women, new evidence suggests that using an oestrogen patch may be safer than taking a pill.

Inhaler to deliver powerful anti-flu drugs

07-Mar-2007 - A new dry power inhaler has been developed to deliver potent anti-influenza drug treatments that last longer and require only a single dose.

Spray-on contraceptives to penetrate $6.7bn market

06-Mar-2007 - Contraceptives delivered by a simple spray onto the skin are being developed in a bid to offer easier, more convenient pregnancy protection.

First anti-psychotic patch in development

06-Mar-2007 - Two US companies have teamed up to develop a prototype patch to deliver an existing anti-psychotic drug through the skin.

Oral strip for generic Zofran

05-Mar-2007 - A new rapidly dissolving oral strip for ondansetron, the active ingredient in GSK's anti-emetic drug Zofran, has been developed in a Swiss-German collaboration.

First six-month cancer dosage introduced to Europe

01-Mar-2007 - MediGene's six-month dosage of its prostate cancer drug Eligard (leuprolide acetate) is now available in Germany, the company announced today.

Implantable/injectable drug delivery market set to hit $12.6bn by 2010

01-Mar-2007 - The implantable/injectable drug delivery market generated record revenues of $9.8bn (€7.4bn) worldwide in 2006 but is set to continue growing, driven by growing demand for novel drug delivery technologies.

Sign up for your free newsletter